- By insider
COO of Abcellera Biologics Inc (30-Year Financial, Insider Trades) Veronique Lecault (insider trades) bought 23,000 shares of ABCL on 12/15/2020 at an average price of $20 a share. The total cost of this purchase was $460,000.
AbCellera Biologics Inc has a market cap of $12.91 billion; its shares were traded at around $48.600000 with and P/S ratio of 3738.46. GuruFocus has detected 1 severe warning sign with AbCellera Biologics Inc. .
Directors and Officers Recent Trades:
-
Director Peter Thiel bought 3,000,000 shares of ABCL stock on 12/15/2020 at the average price of $20.
-
Director John S. Montalbano bought 25,000 shares of ABCL stock on 12/15/2020 at the average price of $20.
-
COO Veronique Lecault bought 23,000 shares of ABCL stock on 12/15/2020 at the average price of $20.
-
Director Michael R Hayden bought 73,665 shares of ABCL stock on 12/15/2020 at the average price of $20.
-
Chief Legal Officer Tryn Stimart bought 500 shares of ABCL stock on 12/15/2020 at the average price of $20.
For the complete insider trading history of ABCL, click here
.This article first appeared on GuruFocus.